Introduction
Hyperandrogenism is not uncommon in young, premenopausal women (most frequently caused by polycystic ovary syndrome) but new onset hyperandrogenism is a relatively rare occurrence in postmenopausal women. In these cases, the investigation should necessarily be directed toward an androgen-secreting tumor, especially if serum androgen concetrations are very high. Severe hyperandrogenism is associated with cardiovascular, respiratory and metabolic complications, partly mediated by hyperinsulinism. (1,2) It also increases the neoplastic risk (endometrial, breast cancer) because of the secondary hyperestrogenism (resulting from the aromatisation of the excessive androgens) (3, 4) 
Case report
We report the case of a 68 years-old woman with a recent history of severe arterial hypertension presenting as cardiogenic pulmonary edema, recentonset diabetes mellitus, severe respiratory failure and marked, progressive obesity. She was referred to our department mainly due to her severely androgenic phenotype (developed during the last 18 months before admission).
The clinical examination showed android obesity, severe male-pattern alopecia (see figure nr 1), marked hirsutism involving the face but especially the trunk, deepening of the voice.
Severe, resistant arterial hypertension with hypertrophic cardiomyopathy and congestive heart failure was also present. The patient associated chronic respiratory failure, severe obstructive sleep apnea syndrome, recent-onset diabetes mellitus (maximum blood glucose 211 mg/dl, HbA1c of 6.8%).
The endocr ine evaluation revealed: erythrocytosis, extremely elevated serum testosterone level, high serum estradiol-by aromatization of androgens, low gonadotropins discordant with the postmenopausal status -caused by the increase in estradiol and testosterone levels-see table nr. 1, normal adrenal function.
Computed tomography of the abdomen showed normal adrenal glands, right ovarian tumor, markedly increased uterine volume with severe endometrial hyperplasia-see figure 2.
Surgery was recommended and performed, with significant early clinical improvement. As soon as 3 weeks after surgery the blood pressure and glycemic control improved markedly. The histopathological examination revealed a benign sex cord-stromal tumor (thecoma) with no suspicious endometrial findings.
Discussion
Severe hyperandrogenism in a postmenopausal woman is a relatively rare occurrence and should raise the suspicion of a tumoral cause. Women with androgen-secreting tumors typically present with recent-onset, rapidly Table 1 . The endocrine evaluation of the patient relationship between serum testosterone levels and several cardiovascular risks factors (eg diabetes mellitus, increased visceral adiposity, insulin resistance and metabolic syndrome). (5, 6) In contrast, in men primarily diagnosed with obesity and metabolic syndrome serum testosterone levels are typically low but whether this is a cause-effect relationship remains to be determined. In contrast, in women, elevated serum androgens levels are positively correlated with obesity and metabolic syndrome. (7) The Women's Ischemia Syndrome Evaluation (WISE) study revealed that in postmenopausal women hyperandrogenism is significantly associated with a higher incidence of central adiposity and coronary arter y disease than women without hyperandrogenemia (8) . The mechanisms behind the differential action of androgens in males and females remain unclear.
Granulosa cell tumors and thecomas are more often hyperestrogenic, but androgenic cases have been reported.(9) Hyperandrogenism of ovarian origin may be associated with endometrial hyperplasia and/or carcinoma (10), especially in postmenopausal women . (11, 12) as a result of increased peripheral estrogen production (aromatisation of androgens). Some postmenopausal women with hyperandrogenism caused by a tumor also experience uterine bleeding due to peripheral aromatization of androgens to estrogens. (13) In almost all cases with severe hyperandrogenism, insulin resistance and hyperinsulinemia are present and women are at increased risk for type 2 diabetes and cardiovascular disease . Additional physical findings may include central obesity, skin tags, and acanthosis nigricans.
Most women with ovarian hyperandrogenism have tissue resistance to insulin that is identified by fasting hyperinsulinemia or subnormal insulinmediated glucose uptake (from euglycemic clamp studies). (14) The molecular basis for the tissue resistance to insulin in these women is not known. 
Conclusions
The presence of severe hyperandrogenism in postmenopausal women is frequently the result of an androgen-secreting tumor and can be associated with important complications.
